-0.0015 (-5.66%)Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Nexalis Therapeutics Limited
Telephone
Address
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.02 - 0.05
Trade Value (12mth)
AU$1,149.00
1 week
20.45%
1 month
26.19%
YTD
10.42%
1 year
-1.14%
All time high
0.42
EPS 3 yr Growth
-32.40%
EBITDA Margin
0.00%
Operating Cashflow
-$1m
Free Cash Flow Return
0.00%
ROIC
0.00%
Interest Coverage
-18.10
Quick Ratio
0.70
Shares Outstanding (Fully Diluted)
218m
HALO Sector
Healthcare
Next Company Report Date
N/A
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
| Date | Announcements |
| 14 May 26 | |
| 13 May 26 | |
| 30 April 26 | |
| 30 April 26 | |
| 30 April 26 |
Historical data
Forecast data
| 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | ||||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | AU$ |  | | | | -0.01 | -0.01 | -0.01 | | | | ||
EPS (Fully Diluted) | AU$ | | | | | -0.01 | -0.01 | -0.01 | | | | ||
Growth | % | | | | | 31.5 | 26.3 | -33.9 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
